Confident Investing Starts With TipRanks Premium

Go Ultimate 55% OFF

DE:P731 Stock Latest News

Company AnnouncementsMedexus Shareholders Back Board, Auditor and Equity Plan at Annual Meeting1M ago

Company AnnouncementsMedexus Pharmaceuticals Earnings Call Highlights GRAFAPEX Momentum2M ago
RatingsAnalyst Lifts Medexus Price Target to C$6.50 and Reiterates Buy on Strong Grafapex-Driven Performance2M ago
Company AnnouncementsMedexus Q1 Profitability Surges on Record GRAFAPEX Performance2M ago
RatingsMedexus: Buy Rating Reiterated as Analyst Sees Leaner Cost Base, Growing U.S. Portfolio and Pipeline Upside Supporting C$6.00 Target Price4M ago

Medexus Earnings Call: GRAFAPEX Offsets Transition Strain

Company AnnouncementsMedexus Earnings Call: GRAFAPEX Offsets Transition Strain4M ago

Pre-EarningsMDP Earnings this Week: How Will it Perform?4M ago

Company AnnouncementsMedexus Advances U.S. GRAFAPEX Rollout While Streamlining Capital Structure6M ago

RatingsMedexus Pharmaceuticals: Channel Headwinds Masking Demand as Strategic Positioning Supports Buy-Rated Risk‑Reward8M ago
Company AnnouncementsMedexus Pharmaceuticals Balances GRAFAPEX Growth With Headwinds8M ago
Pre-EarningsIs MDP a Buy, Before Earnings?8M ago
Company AnnouncementsMedexus Sets Date for Q3 2026 Earnings Call and Webcast9M ago

Medexus Pharmaceuticals Inc.: Stable Growth and Promising Outlook Justify Buy Rating

RatingsMedexus Pharmaceuticals Inc.: Stable Growth and Promising Outlook Justify Buy Rating11M ago

Company AnnouncementsMedexus Secures New Credit Facilities and Plans Share Buyback11M ago

Company AnnouncementsMedexus Pharmaceuticals’ Earnings Call: GRAFAPEX Shines Amid Challenges11M ago

Company AnnouncementsMedexus Pharmaceuticals Reports Strong GRAFAPEX Performance Amidst Revenue Challenges11M ago
Pre-EarningsMedexus Pharmaceuticals (MDP) Q2 Earnings Cheat Sheet11M ago
Company AnnouncementsMedexus Pharmaceuticals to Discuss Q2 2026 Financial Results12M ago
Company AnnouncementsMedexus Pharmaceuticals Announces Election of Directors and Auditor Appointment1y ago

Medexus Pharmaceuticals Earnings Call: Cautious Optimism Amid Challenges

Company AnnouncementsMedexus Pharmaceuticals Earnings Call: Cautious Optimism Amid Challenges1y ago

RatingsBuy Rating Affirmed for Medexus Pharmaceuticals Inc. Based on Solid Financial Performance and Strategic Positioning1y ago

Company AnnouncementsMedexus Pharmaceuticals Reports Strong Q1 2026 Results Driven by GRAFAPEX Launch1y ago